← Back to Search

Time-restricted Eating for Metabolic Disorders (READY Trial)

N/A
Waitlist Available
Led By Amy A Kirkham, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 2, 3, and 4 months post intervention period
Awards & highlights

READY Trial Summary

This trial will study whether a new cancer prevention program can help reduce breast cancer risk factors.

READY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 2, 3, and 4 months post intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 2, 3, and 4 months post intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to TRE for the 16-week intervention
Hemoglobin A1c
Secondary outcome measures
10-year cardiovascular disease risk
Alanine Transaminase
Blood Pressure
+17 more
Other outcome measures
Anxiety
Depression

READY Trial Design

5Treatment groups
Experimental Treatment
Active Control
Group I: Standardized TRE protocol + Peer SupportExperimental Treatment2 Interventions
Participants will be asked to follow a standardized 16:8 TRE protocol with an 11 am to 7 pm eating window for 16 weeks. Each participant will be matched with another participant in the same group to provide peer-based support to adhere to TRE. Study staff will introduce pairs and provide an introduction to TRE and then pairs will meet by phone/video at weeks 1, 3, 6, and 12 at a minimum, with additional contact encouraged.
Group II: Standardized TRE protocol + External SupportExperimental Treatment2 Interventions
Participants will be asked to follow a standardized 16:8 TRE protocol with an 11 am to 7 pm eating window for 16 weeks. Participants receive support to follow the TRE intervention from the study team which will include an initial consultation with a registered dietitian and ongoing tailored feedback via brief support calls from study staff at weeks 1, 3, 6, and 12.
Group III: Personalized TRE protocol + Peer SupportExperimental Treatment2 Interventions
Participants will be asked to follow TRE for 16 weeks with a protocol that is personalized to their preferences within the following pre-specified rules: 1) 8-10 hour eating window; 2) self-selected eating window start time as long as it ends ≥3h before bedtime; 3) if days off are required, aim to do so after following TRE for ≥5 successive days each week. Each participant will be matched with another participant in the same group to provide peer-based support to adhere to TRE. Study staff will introduce pairs and provide an introduction to TRE and then pairs will meet by phone/video at weeks 1, 3, 6, and 12 at a minimum, with additional contact encouraged.
Group IV: Personalized TRE protocol + External SupportExperimental Treatment2 Interventions
Participants will be asked to follow TRE for 16 weeks with a protocol that is personalized to their preferences within the following pre-specified rules: 1) 8-10 hour eating window; 2) self-selected eating window start time as long as it ends ≥3h before bedtime; 3) if days off are required, aim to do so after following TRE for ≥5 successive days each week. Participants receive support to follow the TRE intervention from the study team which will include an initial consultation with a registered dietitian and ongoing tailored feedback via brief support calls from study staff at weeks 1, 3, 6, and 12.
Group V: Control GroupActive Control1 Intervention
Participants will be asked to maintain their usual diet and physical activity patterns for 16 weeks. They will receive the same number and timing of calls from study staff as the other groups (at randomization, 1, 3, 6, 12 weeks).

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
687 Previous Clinical Trials
1,018,192 Total Patients Enrolled
Amy A Kirkham, PhDPrincipal InvestigatorUniversity of Toronto
1 Previous Clinical Trials
58 Total Patients Enrolled

Media Library

Standardized TRE Protocol Clinical Trial Eligibility Overview. Trial Name: NCT05454943 — N/A
Metabolic Disorders Research Study Groups: Personalized TRE protocol + Peer Support, Personalized TRE protocol + External Support, Control Group, Standardized TRE protocol + External Support, Standardized TRE protocol + Peer Support
Metabolic Disorders Clinical Trial 2023: Standardized TRE Protocol Highlights & Side Effects. Trial Name: NCT05454943 — N/A
Standardized TRE Protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT05454943 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being welcomed for this clinical experiment?

"Clinicaltrials.gov reports that this clinical trial, which was initiated on the 7th of July 2022, is presently recruiting participants. The listing was last amended on the 11th of July 2022."

Answered by AI

How many participants are signing up to be part of this experiment?

"Affirmative. According to information hosted on clinicaltrials.gov, this trial is presently in need of patient recruitment and was posted online on July 7th 2022. The most recent edit was made five days later, with the ultimate goal being 178 participants at a single location."

Answered by AI

What are the fundamental aims of this research endeavor?

"This clinical trial will run for 16 Weeks, with the primary outcome being compliance to a TRE program. Secondary indicators of success include HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), physical activity monitored via FitBit Inspire 2 over 7 days, and Metabolic syndrome as defined by NCEP/ATP III criteria."

Answered by AI
~65 spots leftby Apr 2025